Understanding how a specific protein affects the processing of RNA in parasites that cause diseases.
The essential role of cyclin-dependent kinase CRK9 in trypanosome pre-mRNA processing
This study is looking at a specific protein in trypanosome parasites, which cause diseases like African Sleeping Sickness and Chagas disease, to see how it helps them process their genetic material differently than humans, with the hope of finding new ways to treat these illnesses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11040299 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called cyclin-dependent kinase CRK9 in the processing of RNA in trypanosome parasites, which are responsible for diseases like African Sleeping Sickness and Chagas disease. By focusing on how these parasites process their genetic material differently from humans, the researchers aim to identify new therapeutic strategies. They utilize a specialized cell line to inhibit CRK9 and observe the effects on RNA splicing, which is crucial for the parasites' survival. This approach could lead to the development of new treatments for these neglected tropical diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by African Sleeping Sickness or Chagas disease.
Not a fit: Patients with other unrelated conditions or those not infected with trypanosome parasites may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, effective treatments for diseases caused by trypanosome parasites.
How similar studies have performed: Other research has shown promise in targeting unique aspects of trypanosome biology, suggesting that this approach could yield significant advancements.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Gunzl, Arthur — University of Connecticut Sch of Med/dnt
- Study coordinator: Gunzl, Arthur
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.